STOCK TITAN
  1. Home
  2. Sec-filings
  3. LONA
  4. [Form 4] LeonaBio, Inc. Insider Trading Activity

LeonaBio (LONA) director awarded 28,000 stock options at $8.35 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LeonaBio, Inc. director Romano Kelly reported receiving a grant of stock options covering 28,000 shares of common stock. The options have an exercise price of $8.35 per share and expire on June 22, 2036.

The options will vest on the earlier of June 23, 2027, or the day immediately before the next annual stockholders’ meeting that occurs after June 22, 2026. The grant was made under LeonaBio’s Outside Director Compensation Policy and reflects equity-based compensation rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Romano Kelly A
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 28,000 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 28,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Option grant size 28,000 options Stock Option (Right to Buy) covering common stock
Exercise price $8.35 per share Conversion or exercise price for the stock options
Expiration date June 22, 2036 Final date to exercise the options
Shares underlying options 28,000 shares Common stock underlying the derivative security
Vesting trigger Earlier of June 23, 2027 or pre-next annual meeting Vesting condition from compensation policy footnote
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Outside Director Compensation Policy financial
"The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy."
vest financial
"The shares subject to the option will vest on the earlier of (i) June 23, 2027..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Romano Kelly A
(Last)(First)(Middle)
C/O LEONABIO, INC.
18706 NORTH CREEK PARKWAY, SUITE 104
(Street)
BOTHELL WASHINGTON 98011
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
LeonaBio, Inc. [ LONA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$8.3506/23/2026A28,000 (1)06/22/2036Common Stock28,000$028,000D
Explanation of Responses:
1. The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.
/s/ Mark Worthington, Attorney in fact for Kelly A. Romano06/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did LeonaBio (LONA) director Romano Kelly report in this Form 4?

Romano Kelly reported receiving a grant of stock options for 28,000 shares of LeonaBio common stock. These options were awarded as director compensation, not bought in the open market, and give the right to purchase shares at a fixed exercise price in the future.

What are the key terms of Romano Kelly’s LeonaBio (LONA) stock option grant?

The grant covers 28,000 shares with an exercise price of $8.35 per share and an expiration date of June 22, 2036. These terms define how many shares can be purchased, at what price, and the latest date the options can be exercised.

When do the LeonaBio (LONA) stock options granted to Romano Kelly vest?

The options vest on the earlier of June 23, 2027, or the day immediately before the next annual stockholders’ meeting that occurs after June 22, 2026. Vesting determines when the director can begin exercising the options for LeonaBio shares.

Is Romano Kelly’s LeonaBio (LONA) Form 4 transaction an open-market buy or sell?

No, the filing shows a grant of stock options as compensation, coded as an acquisition (A), not an open-market transaction. The company awarded options with a $8.35 exercise price, and no cash purchase or sale of common shares in the market is reported.

How many LeonaBio (LONA) derivative securities does Romano Kelly hold after this grant?

Following the grant, Romano Kelly holds 28,000 stock options according to the filing’s totals. These options, linked to LeonaBio common stock, represent potential future share ownership if exercised in line with the vesting schedule and expiration date.